Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005034

Sponsors and Collaborators

Eastern Cooperative Oncology Group

National Cancer Institute (NCI)

Southwest Oncology Group

Investigators


Study Chair:	David H. Lawson, MD	Emory University

Study Chair:	Kim Allyson Margolin, MD	Beckman Research Institute